These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12606770)

  • 1. Small ligands modulating the activity of mammalian adenylyl cyclases: a novel mode of inhibition by calmidazolium.
    Haunsø A; Simpson J; Antoni FA
    Mol Pharmacol; 2003 Mar; 63(3):624-31. PubMed ID: 12606770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of human adenylyl cyclase IX reveals inhibition by Ca(2+)/Calcineurin and differential mRNA plyadenylation.
    Paterson JM; Smith SM; Simpson J; Grace OC; Sosunov AA; Bell JE; Antoni FA
    J Neurochem; 2000 Oct; 75(4):1358-67. PubMed ID: 10987815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein associated with Myc (PAM) is a potent inhibitor of adenylyl cyclases.
    Scholich K; Pierre S; Patel TB
    J Biol Chem; 2001 Dec; 276(50):47583-9. PubMed ID: 11590159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor.
    Lübker C; Seifert R
    PLoS One; 2015; 10(5):e0124017. PubMed ID: 25946093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An isoform-specific interaction of the membrane anchors affects mammalian adenylyl cyclase type V activity.
    Seebacher T; Linder JU; Schultz JE
    Eur J Biochem; 2001 Jan; 268(1):105-10. PubMed ID: 11121109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, mechanism, and regulation of soluble adenylyl cyclases - similarities and differences to transmembrane adenylyl cyclases.
    Steegborn C
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt B):2535-47. PubMed ID: 25193033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capturing adenylyl cyclases as potential drug targets.
    Pierre S; Eschenhagen T; Geisslinger G; Scholich K
    Nat Rev Drug Discov; 2009 Apr; 8(4):321-35. PubMed ID: 19337273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of soluble forms of nonchimeric type V adenylyl cyclases.
    Scholich K; Barbier AJ; Mullenix JB; Patel TB
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2915-20. PubMed ID: 9096321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin-Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin.
    Hayes MP; Soto-Velasquez M; Fowler CA; Watts VJ; Roman DL
    ACS Chem Neurosci; 2018 Feb; 9(2):346-357. PubMed ID: 28968502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrphostins are inhibitors of guanylyl and adenylyl cyclases.
    Jaleel M; Shenoy AR; Visweswariah SS
    Biochemistry; 2004 Jun; 43(25):8247-55. PubMed ID: 15209521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raf kinase activation of adenylyl cyclases: isoform-selective regulation.
    Ding Q; Gros R; Gray ID; Taussig R; Ferguson SS; Feldman RD
    Mol Pharmacol; 2004 Oct; 66(4):921-8. PubMed ID: 15385642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azido-iodo-phenyl-analogs of 2',5'-dideoxy-adenosine as photoaffinity ligands for adenylyl cyclase.
    Shoshani I; Qui H; Johnson F; Taussig R; Johnson RA
    Biochim Biophys Acta; 1995 Aug; 1245(1):37-42. PubMed ID: 7654764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative electrostatic analysis of adenylyl cyclase for isoform dependent regulation properties.
    Tong R; Wade RC; Bruce NJ
    Proteins; 2016 Dec; 84(12):1844-1858. PubMed ID: 27667304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between Activity and Domain Complementation in Adenylyl Cyclase Demonstrated with a Novel Fluorescence Resonance Energy Transfer Sensor.
    Ritt M; Sivaramakrishnan S
    Mol Pharmacol; 2016 Apr; 89(4):407-12. PubMed ID: 26801393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells.
    Yoshimura M; Cooper DM
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6716-20. PubMed ID: 1379717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide induces somatolactin release from cultured goldfish pituitary cells.
    Azuma M; Tanaka M; Nejigaki Y; Uchiyama M; Takahashi A; Shioda S; Matsuda K
    Peptides; 2009 Jul; 30(7):1260-6. PubMed ID: 19540424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial agonist clonidine mediates alpha(2)-AR subtypes specific regulation of cAMP accumulation in adenylyl cyclase II transfected DDT1-MF2 cells.
    Limon-Boulez I; Bouet-Alard R; Gettys TW; Lanier SM; Maltier JP; Legrand C
    Mol Pharmacol; 2001 Feb; 59(2):331-8. PubMed ID: 11160870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium preferentially inhibits adenylyl cyclase V and VII isoforms.
    Mann L; Heldman E; Shaltiel G; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):533-9. PubMed ID: 18205980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.
    Brust TF; Alongkronrusmee D; Soto-Velasquez M; Baldwin TA; Ye Z; Dai M; Dessauer CW; van Rijn RM; Watts VJ
    Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based development of novel adenylyl cyclase inhibitors.
    Schlicker C; Rauch A; Hess KC; Kachholz B; Levin LR; Buck J; Steegborn C
    J Med Chem; 2008 Aug; 51(15):4456-64. PubMed ID: 18630896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.